Stock Track | WUXI BIO Soars 5.01% in Intraday Trading on $400 Million Share Buyback Announcement

Stock Track
05/26

WUXI BIO's stock surged 5.01% during intraday trading on Tuesday, following the company's announcement of a significant share repurchase program.

The biopharmaceutical company revealed plans to buy back up to US$400 million worth of its shares in the open market. Management stated that the current market price does not reflect the company's intrinsic value or actual business prospects, viewing the substantial buyback authorization as a strong signal of confidence in its future development outlook.

The board resolution, approved on May 24, 2026, authorizes the repurchase of up to 407 million shares, representing approximately 10% of the total issued shares. The company emphasized that all buybacks will be executed in compliance with applicable regulations and market conditions.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10